Group One Trading
KYTH

Group One Trading’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Group One Trading’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-15,100
Closed -$1.13M – 5586
2015
Q3 		$1.13M Sell
15,100
-25,600
-63% -$1.91M 0.02% 1151
2015
Q2 		$3.06M Buy
40,700
+7,600
+23% +$407K 0.04% 518
2015
Q1 		$1.66M Buy
33,100
+30,100
+1,003% +$1.26M 0.03% 748
2014
Q4 		$104K Buy
3,000
+2,000
+200% +$69.8K ﹤0.01% 2819
2014
Q3 		$33K Buy
1,000
+800
+400% +$28.2K ﹤0.01% 3822
2014
Q2 		$8K Sell
200
-4,400
-96% -$154K ﹤0.01% 4626
2014
Q1 		$183K Sell
4,600
-400
-8% -$17.9K ﹤0.01% 2519
2013
Q4 		$186K Buy
+5,000
New +$207K ﹤0.01% 2500

Group One Trading's KYTH Position: Q4 2015 in Review

Group One Trading sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 7,719 shares — an estimated $579K sold.

Group One Trading first reported a position in KYTH in Q2 2014 and held it in 5 quarters. The position peaked at $579K in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Group One Trading reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Group One Trading sold 7,719 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $579K.
  • Group One Trading first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2014 and held it in 5 quarters.
  • Group One Trading's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $579K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Group One Trading's 13F filing for Q4 2015, filed 11 Feb 2016.